⌘K

Login Start Free

Home/Filings/4/0001127602-18-028453

4//SEC Filing

Ehlers Michael D 4

Accession 0001127602-18-028453

CIK 0000875045other

View on SEC.gov Company Profile

Filed

Sep 26, 8:00 PM ET

Accepted

Sep 27, 4:16 PM ET

Size

4.7 KB

Accession

0001127602-18-028453

Insider Transaction Report

Form 4

Period: 2018-09-26

BIOGEN INC.BIIB

Ehlers Michael D

EVP, Research and Development

Transactions

Sale
Common Stock
2018-09-26$350.00/sh−1,000$350,000→ 4,281.171 total

Footnotes (1)

[F1]Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOGEN INC.

CIK 0000875045

Entity typeother

Related Parties

1

filerCIK 0001674364

Filing Metadata

Form type: 4
Filed: Sep 26, 8:00 PM ET
Accepted: Sep 27, 4:16 PM ET
Size: 4.7 KB

View on SEC.gov